Effect of Myocardial Viability Assessed by Cardiac Magnetic Resonance on Survival in Patients With Severe Left Ventricular Dysfunction
Related Experiment Video
Updated: Nov 14, 2025

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Jonathan Yap1, Fang Yi Lim1, Fei Gao1
1Cardiology, National Heart Centre Singapore Singapore Singapore.
Insights
Assessing myocardial viability with cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE) helps predict survival benefits from coronary artery bypass grafting (CABG) in ischemic heart failure patients. This finding requires validation in larger studies.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Medical Diagnostics
Background:
- Myocardial viability assessment is crucial for revascularization decisions in ischemic heart failure.
- The prognostic utility of cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE) remains debated.
- Left ventricular ejection fraction (LVEF) ≤35% defines the study cohort with ischemic heart failure.
Purpose of the Study:
- To evaluate the prognostic value of CMR-LGE for predicting outcomes in ischemic heart failure patients undergoing revascularization.
- To determine if LGE extent influences survival benefit from coronary artery bypass grafting (CABG) versus optimal medical therapy (OMT).
Main Methods:
- Retrospective analysis of 165 ischemic heart failure patients (LVEF ≤35%) who underwent CMR before CABG or OMT.
- Myocardial segments with LGE >50% wall thickness were classified as non-viable.
- Outcomes assessed included all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events.
Main Results:
- A higher number of non-viable myocardial segments correlated with increased all-cause and cardiovascular mortality in the CABG group (P<0.05).
- This association was not significant in the optimal medical therapy (OMT) group (P>0.05).
- Anterior wall viability did not impact patient outcomes.
Conclusions:
- CMR-assessed myocardial viability may identify patients who benefit differentially from CABG.
- These findings suggest LGE could guide revascularization strategies in ischemic heart failure.
- Larger prospective studies are needed to validate these hypotheses.
Abstract:
Myocardial viability assessment in revascularization of ischemic heart failure remains controversial. This study evaluated the prognostic utility of cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE) in ischemic heart failure. This study retrospectively analyzed subjects with ischemic heart failure and left ventricular ejection fraction (LVEF) ≤35%, who underwent CMR at a single center in 2004-2014 before undergoing coronary artery bypass grafting (CABG) or optimal medical therapy (OMT). Analyses were stratified by treatment. Myocardial segments were deemed non-viable if LGE exceeded 50% wall thickness. Overall and anterior viability were assessed. Outcomes were all-cause mortality, cardiovascular (CV) mortality and major adverse CV events. Among 165 subjects (mean (±SD) age 57.5±8.5 years, 152 males), 79 underwent CABG and 86 received OMT. A greater number of non-viable segments was significantly associated with higher all-cause and CV mortality in the CABG group (adjusted hazard ratios 1.17 [95% confidence interval {CI} 1.01-1.37; P=0.04] and 1.25 [95% CI 1.01-1.56; P=0.045], respectively), but not in the OMT (P>0.05) group. Anterior wall viability did not affect outcomes. The extent of myocardial viability assessed by LGE appeared to identify patients with a differential survival benefit from CABG in this retrospective, small cohort study. These findings raise interesting hypotheses that need to be validated in larger prospective studies.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy